Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut bacterial microbiome composition and statin intake—A systematic review
Andréia Dias, Gonçalo Cordeiro, María Manuela Estevinho, et al.
Pharmacology Research & Perspectives (2020) Vol. 8, Iss. 3
Open Access | Times Cited: 49

Showing 1-25 of 49 citing articles:

2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
Scott M. Grundy, Neil J. Stone, Alison Bailey, et al.
Circulation (2019) Vol. 139, Iss. 25
Open Access | Times Cited: 5479
Neurodegenerative and Neurodevelopmental Diseases and the Gut-Brain Axis: The Potential of Therapeutic Targeting of the Microbiome
Brian Bicknell, Ann Liebert, Thomas J. Borody, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 11, pp. 9577-9577
Open Access | Times Cited: 68
The Implication of the Gut Microbiome in Heart Failure
Vasile Valeriu Lupu, Anca Adam Răileanu, Cristina Maria Mihai, et al.
Cells (2023) Vol. 12, Iss. 8, pp. 1158-1158
Open Access | Times Cited: 46
Polyphenols synergistic drugs to ameliorate non-alcoholic fatty liver disease via signal pathway and gut microbiota: A review
Hongcai Li, Jingjing Liang, Mengzhen Han, et al.
Journal of Advanced Research (2024)
Open Access | Times Cited: 19
Prophylactic Supplementation with Lactobacillus Reuteri or Its Metabolite GABA Protects Against Acute Ischemic Cardiac Injury
Jiawan Wang, Hao Zhang, Yuan Hai-long, et al.
Advanced Science (2024) Vol. 11, Iss. 18
Open Access | Times Cited: 12
Approach to the diagnosis and management of dysbiosis
Kannayiram Alagiakrishnan, Joao Morgadinho, Tyler Halverson
Frontiers in Nutrition (2024) Vol. 11
Open Access | Times Cited: 12
Targeting the human gut microbiome with small-molecule inhibitors
Amelia Y. M. Woo, Miguel A. Aguilar Ramos, Rohan Narayan, et al.
Nature Reviews Chemistry (2023) Vol. 7, Iss. 5, pp. 319-339
Closed Access | Times Cited: 22
Oral Cardiac Drug–Gut Microbiota Interaction in Chronic Heart Failure Patients: An Emerging Association
Ioannis Paraskevaidis, Αlexandros Briasoulis, Elias Tsougos
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1716-1716
Open Access | Times Cited: 6
Associations between dysbiosis-inducing drugs, overall survival and tumor response in patients treated with immune checkpoint inhibitors
L Gaucher, Leslie Adda, Alice Séjourné, et al.
Therapeutic Advances in Medical Oncology (2021) Vol. 13
Open Access | Times Cited: 39
The Intestinal Effect of Atorvastatin: Akkermansia muciniphila and Barrier Function
Tingting Cheng, Changkun Li, Linyan Shen, et al.
Frontiers in Microbiology (2022) Vol. 12
Open Access | Times Cited: 20
Polypharmacy With High Drug Burden Index (DBI) Alters the Gut Microbiome Overriding Aging Effects and Is Reversible With Deprescribing
Gizem Gemikonakli, John Mach, Fan Zhang, et al.
The Journals of Gerontology Series A (2022) Vol. 78, Iss. 2, pp. 213-222
Open Access | Times Cited: 17
Cholesterol Gallstones and Long-Term Use of Statins: Is Gut Microbiota Dysbiosis Bridging over Uncertainties?
Doina Georgescu, Daniel-Florin Lighezan, Ioana Ioniţă, et al.
Diagnostics (2024) Vol. 14, Iss. 12, pp. 1234-1234
Open Access | Times Cited: 3
The Bidirectional Relationship Between Cardiovascular Medications and Oral and Gut Microbiome Health: A Comprehensive Review
Gangani Dharmarathne, Samia Kazi, Shalinie King, et al.
Microorganisms (2024) Vol. 12, Iss. 11, pp. 2246-2246
Open Access | Times Cited: 3
Lipid metabolism correction with statins and probiotics
Н. В. Барышникова, V. M. L’Nyavina, Yury P. Uspenskiy, et al.
Experimental and Clinical Gastroenterology (2025), Iss. 9, pp. 161-174
Closed Access
Targets of statins intervention in LDL-C metabolism: Gut microbiota
ChangXin Sun, ZePing Wang, LanQing Hu, et al.
Frontiers in Cardiovascular Medicine (2022) Vol. 9
Open Access | Times Cited: 15
Portal Vein Thrombosis in Patients with Liver Cirrhosis: What Went Wrong?
Doina Georgescu, Oana Ancusa, Daniel Azoulay, et al.
International Journal of General Medicine (2023) Vol. Volume 16, pp. 3889-3906
Open Access | Times Cited: 8
Long-Term Statin Use, Total Cholesterol Level, and Risk of Colorectal Cancer: A Prospective Cohort Study
Yin Zhang, Kana Wu, Andrew T. Chan, et al.
The American Journal of Gastroenterology (2021)
Open Access | Times Cited: 19
Multifaceted Impacts of Periodontal Pathogens in Disorders of the Intestinal Barrier
Yingman Liu, Wenxuan Huang, Jiaqi Wang, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 18
Microbiota and Its Impact on the Immune System in COVID-19—A Narrative Review
Marzena Jabczyk, Justyna Nowak, Bartosz Hudzik, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 19, pp. 4537-4537
Open Access | Times Cited: 17
Human Microbiota Impact on the Efficacy of Pharmacological Treatments
Muzzammil Siraj, Hasnain Siraj, Safdar Miran, et al.
Advances in medical technologies and clinical practice book series (2024), pp. 212-233
Closed Access | Times Cited: 2
COPD Pathogenesis and Alterations in the Oral, Lung, and Gut Microbiomes
Nobuhiro Asai, Yoshihiro Ohkuni, Hideo Kato, et al.
Microbiology Research (2024) Vol. 15, Iss. 3, pp. 1605-1615
Open Access | Times Cited: 2
A gut feeling of statin
Jianqing She, Lizhe Sun, Yue Yu, et al.
Gut Microbes (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 2
Nonalcoholic Fatty Liver Disease—A Novel Risk Factor for Recurrent Clostridioides difficile Infection
Lara Šamadan, Mia Jeličić, Adriana Vince, et al.
Antibiotics (2021) Vol. 10, Iss. 7, pp. 780-780
Open Access | Times Cited: 15
Reduced gut microbial diversity in familial hypercholesterolemia with no effect of omega-3 polyunsaturated fatty acids intervention – a pilot trial
Christopher Storm-Larsen, Liv Nesse Hande, Martin Kummen, et al.
Scandinavian Journal of Clinical and Laboratory Investigation (2022) Vol. 82, Iss. 5, pp. 363-370
Open Access | Times Cited: 10
Page 1 - Next Page

Scroll to top